Anti-Fungal Antiviral Agents Flashcards
why might fungal infections be increasing (9)
- use of agents that disrupt normal host microflora - anti-biotics
- failure to develop a strong immune system or immunosuppressive drugs
- patient management that suppresses the immune response
- chemotherapy, HIV/AIDS, transplants, steroid treatment
- diabetes
- antibiotic use
- age
- invasive surgical procedures that introduce fungi (IV lines, etc)
- hospital acquired infection
what is the selective toxicity of antifungal agents
need to targe features of fungus not found in host
however fungi are eukaryotes like animals and humans
what are the sites of action of common antifungal drugs
what are the classification of antifungal drugs
- superficial/systemic infection
- topical/systemic administration of drug
- antifungals/synthetic agents
- fungicidal/fungistatic
- chemical subclass
what are the chemical subclassification
- allylamines
- azoles
- polyenes
- glucan synthesis (cell wall) inhibitors
- antimetabolites
- griseofulvin
- other agents
what are the selective targets for antifungal drugs-1
ergosterol (rather than cholesterol) is the main fungal cell membrane sterol
which 3 drug classes targe ergosterol in the fungal cell membrane
- allyalmines
- azoles
- amphotericin B (in the class called polyenes)
what is the pathway in biosynthesis of ergosterol
acetyl coA –> squalene (squalene epoxidase) –> lanosterol (14-sterol demethylase) –> ergosterol
what are allylamines (ex, mechanism of action, spectrum, side effects, routes, pharmacokinetics)
dermatophyte infections only
ex: terbinafine
mechanism of action: inhibits ergosterol biosynthesis via inhibition of squalene epoxidase (fungicidal)
spectrum: dermatophytes
side effects: generally transient and mild (GIT and skin)
routes: oral and topical
pharmacokinetics: highly lipophilic (persists in skin)
what is azoles-1 topical (ex, mechanism of action, spectrum, side effects)
examples: clotrimazole; enilconazole, miconazole –> lots of topical azoles (main use is topical for superficial mucous membrane and skin infection)
mechanism of action: inhibition of cytP450 dependent 14-sterol de-methylase
spectrum: broad spectrum (generally fungistatic; prolonged treatment)
side effects: GIT, anorexia, hepatotoxicity, suppression of steroid production (ketoconazole), teratogenic
what are examples of veterinary licensced azoles
what are azoles-2- systemic
triazoles for serious systemic mycoses
fluconazole, itraconazole, voriconazole and posaconazole
what is the drug of choice for histoplasmosis
intraconazole: drug of choice for histoplasmosis
routes: oral
fluconazole, itraconazole: lipophilic, highly plasma protein bound, hepatic metabolism and excretion in feces
fluconazole: water soluble and can be given i.v minimally plasma protein bound, minimally metabolized, 80% excreted by kidney unchanged
what are the mechanisms of resistance to azole antifungal drugs (6)
- membrane changes lead to reduce drug uptake
- mutation of the target enzyme
- over production of target enzyme
- modification of the ergosterol biosynthesis pathway
- drug efflux due to up-regulation ABC transporters, MFS transporters
- biofilm formation
what are polyenes (ex, mechanism of action, spectrum, side effects, routes, pharmokinetics)
examples: amphotericin B, nystatin
mechanism of action: binds to ergosterol, disrupts osmotic integrity of the membrane by forming pores –> ions leak from cell –> cidal and oxidative damage
spectrum: broad spectrum
side effects: nephrotoxicity (i.v), hypokalemia, thrombophlebitis
routes: depends on preparation –> nystatin topical
pharmacokinetics: poorly water soluble (amphotericin B is forms a colloid in solution for injection), poor absorption from GIR